Literature DB >> 20212486

Cellular targets for influenza drugs.

Ji-Young Min, Kanta Subbarao.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20212486      PMCID： PMC3397661          DOI： 10.1038/nbt0310-239

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN： 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  13 in total

Review 1.  The war against influenza: discovery and development of sialidase inhibitors.

Authors:  Mark von Itzstein
Journal:  Nat Rev Drug Discov       Date:  2007-12       Impact factor: 84.694

2.  Genome-wide RNAi screen reveals a specific sensitivity of IRES-containing RNA viruses to host translation inhibition.

Authors:  Sara Cherry; Tammy Doukas; Susan Armknecht; Sean Whelan; Hui Wang; Peter Sarnow; Norbert Perrimon
Journal:  Genes Dev       Date:  2005-02-15       Impact factor: 11.361

3.  CCR5 deficiency is a risk factor for early clinical manifestations of West Nile virus infection but not for viral transmission.

Authors:  Jean K Lim; David H McDermott; Andrea Lisco; Gregory A Foster; David Krysztof; Dean Follmann; Susan L Stramer; Philip M Murphy
Journal:  J Infect Dis       Date:  2010-01-15       Impact factor: 5.226

4.  Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication.

Authors:  Alexander Karlas; Nikolaus Machuy; Yujin Shin; Klaus-Peter Pleissner; Anita Artarini; Dagmar Heuer; Daniel Becker; Hany Khalil; Lesley A Ogilvie; Simone Hess; André P Mäurer; Elke Müller; Thorsten Wolff; Thomas Rudel; Thomas F Meyer
Journal:  Nature       Date:  2010-01-17       Impact factor: 49.962

5.  Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication.

Authors:  Renate König; Yingyao Zhou; Daniel Elleder; Tracy L Diamond; Ghislain M C Bonamy; Jeffrey T Irelan; Chih-Yuan Chiang; Buu P Tu; Paul D De Jesus; Caroline E Lilley; Shannon Seidel; Amanda M Opaluch; Jeremy S Caldwell; Matthew D Weitzman; Kelli L Kuhen; Sourav Bandyopadhyay; Trey Ideker; Anthony P Orth; Loren J Miraglia; Frederic D Bushman; John A Young; Sumit K Chanda
Journal:  Cell       Date:  2008-10-03       Impact factor: 41.582

6.  RNA interference screen for human genes associated with West Nile virus infection.

Authors:  Manoj N Krishnan; Aylwin Ng; Bindu Sukumaran; Felicia D Gilfoy; Pradeep D Uchil; Hameeda Sultana; Abraham L Brass; Rachel Adametz; Melody Tsui; Feng Qian; Ruth R Montgomery; Sima Lev; Peter W Mason; Raymond A Koski; Stephen J Elledge; Ramnik J Xavier; Herve Agaisse; Erol Fikrig
Journal:  Nature       Date:  2008-09-11       Impact factor: 49.962

7.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation.

Authors:  Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; T Jake Liang; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

8.  Identification of host proteins required for HIV infection through a functional genomic screen.

Authors:  Abraham L Brass; Derek M Dykxhoorn; Yair Benita; Nan Yan; Alan Engelman; Ramnik J Xavier; Judy Lieberman; Stephen J Elledge
Journal:  Science       Date:  2008-01-10       Impact factor: 47.728

9.  The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus.

Authors:  Abraham L Brass; I-Chueh Huang; Yair Benita; Sinu P John; Manoj N Krishnan; Eric M Feeley; Bethany J Ryan; Jessica L Weyer; Louise van der Weyden; Erol Fikrig; David J Adams; Ramnik J Xavier; Michael Farzan; Stephen J Elledge
Journal:  Cell       Date:  2009-12-24       Impact factor: 41.582

10.  Drosophila RNAi screen identifies host genes important for influenza virus replication.

Authors:  Linhui Hao; Akira Sakurai; Tokiko Watanabe; Ericka Sorensen; Chairul A Nidom; Michael A Newton; Paul Ahlquist; Yoshihiro Kawaoka
Journal:  Nature       Date:  2008-07-09       Impact factor: 49.962
View more
  14 in total

Review 1.  Uncovering the global host cell requirements for influenza virus replication via RNAi screening.

Authors:  Silke Stertz; Megan L Shaw
Journal:  Microbes Infect       Date:  2011-01-27       Impact factor: 2.700

2.  Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.

Authors:  Randal A Byrn; Steven M Jones; Hamilton B Bennett; Chris Bral; Michael P Clark; Marc D Jacobs; Ann D Kwong; Mark W Ledeboer; Joshua R Leeman; Colleen F McNeil; Mark A Murcko; Azin Nezami; Emanuele Perola; Rene Rijnbrand; Kumkum Saxena; Alice W Tsai; Yi Zhou; Paul S Charifson
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

Review 3.  The virus as metabolic engineer.

Authors:  Nathaniel D Maynard; Miriam V Gutschow; Elsa W Birch; Markus W Covert
Journal:  Biotechnol J       Date:  2010-07       Impact factor: 4.677

4.  Nuclear magnetic resonance reveals a two hairpin equilibrium near the 3'-splice site of influenza A segment 7 mRNA that can be shifted by oligonucleotides.

Authors:  Andrew D Kauffmann; Scott D Kennedy; Walter N Moss; Elzbieta Kierzek; Ryszard Kierzek; Douglas H Turner
Journal:  RNA       Date:  2022-01-04       Impact factor: 4.942

5.  In vivo analysis of influenza A mRNA secondary structures identifies critical regulatory motifs.

Authors:  Lisa Marie Simon; Edoardo Morandi; Anna Luganini; Giorgio Gribaudo; Luis Martinez-Sobrido; Douglas H Turner; Salvatore Oliviero; Danny Incarnato
Journal:  Nucleic Acids Res       Date:  2019-07-26       Impact factor: 16.971

6.  Targeting cell division cycle 25 homolog B to regulate influenza virus replication.

Authors:  Olivia Perwitasari; Ana Claudia Torrecilhas; Xiuzhen Yan; Scott Johnson; Caleb White; S Mark Tompkins; Ralph A Tripp
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

7.  Identification of Host Kinase Genes Required for Influenza Virus Replication and the Regulatory Role of MicroRNAs.

Authors:  Abhijeet Bakre; Lauren E Andersen; Victoria Meliopoulos; Keegan Coleman; Xiuzhen Yan; Paula Brooks; Jackelyn Crabtree; S Mark Tompkins; Ralph A Tripp
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 8.  New treatments for influenza.

Authors:  Sailen Barik
Journal:  BMC Med       Date:  2012-09-13       Impact factor: 8.775

Review 9.  Systematic approaches towards the development of host-directed antiviral therapeutics.

Authors:  Andrew Prussia; Pahk Thepchatri; James P Snyder; Richard K Plemper
Journal:  Int J Mol Sci       Date:  2011-06-15       Impact factor: 5.923

10.  EHFPI: a database and analysis resource of essential host factors for pathogenic infection.

Authors:  Yang Liu; Dafei Xie; Lu Han; Hui Bai; Fei Li; Shengqi Wang; Xiaochen Bo
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.